Loading...
Clinical efficacy, safety, and tolerability of fingolimod for the treatment of relapsing-remitting multiple sclerosis
Fingolimod is a selective immunosuppressive agent approved worldwide for the treatment of relapsing-remitting multiple sclerosis (MS), a chronic and potentially disabling neurological condition. Randomized double-blind clinical trials have shown that fingolimod significantly reduces relapse rate and...
Na minha lista:
| Udgivet i: | Drug Healthc Patient Saf |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Dove Medical Press
2015
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4686225/ https://ncbi.nlm.nih.gov/pubmed/26715860 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DHPS.S69640 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|